http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019518767-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D519-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-499 |
| filingDate | 2017-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2019518767-A |
| titleOfInvention | CXCR4 inhibitors and uses thereof |
| abstract | The present invention provides compounds, compositions thereof, and methods of using them. Compounds of the invention, and pharmaceutically acceptable compositions thereof, have now been found to be effective as CXCR4 inhibitors. In one aspect, the invention provides a compound of formula I or a pharmaceutically acceptable salt thereof, wherein each variable group is defined and described herein. The compounds of the invention, and pharmaceutically acceptable compositions thereof, are useful for the treatment of various diseases, disorders or conditions associated with CXC receptor type 4 (CXCR4). Such diseases, disorders or conditions include cell proliferative disorders such as those described herein (eg, cancer). |
| priorityDate | 2016-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 1852.